Avidity is hoping to follow in the footsteps of Sarepta, which has launched a series of exon-skipping therapies for DMD, targeting exons 51, 53, and 45, that brought in around $1 billion in sales ...

Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) will be an option for many more patients in the US after the FDA expanded the breadth of its approved labelling. Elevidys ...

All the mouthwashes below are alcohol-free. My dentist recommended this fluoride mouthwash years ago and I’ve used it ever since. It helps prevent cavities, strengthen enamel and freshen breath ...